SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT

[1]  C. Cyran,et al.  PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions , 2020, European Radiology Experimental.

[2]  S. Ikeda,et al.  Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report. , 2020, Immunotherapy.

[3]  B. Krause,et al.  FDG PET Hybrid Imaging. , 2020, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[4]  David R. Jones,et al.  SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  S. Sugita,et al.  Exceptionally rapid response to pembrolizumab in a SMARCA4‐deficient thoracic sarcoma overexpressing PD‐L1: A case report , 2019, Thoracic cancer.

[6]  A. Cesne,et al.  Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  M. Tsuboi,et al.  Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report , 2019, Thoracic cancer.

[8]  J. Blay,et al.  SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses , 2019, The American journal of surgical pathology.

[9]  X. Buy,et al.  Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients , 2019, European Radiology.

[10]  Publisher's Note , 2018, Anaesthesia.

[11]  T. Kohno,et al.  Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities , 2017, Modern Pathology.

[12]  N. Girard,et al.  SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas , 2015, Nature Genetics.